Use of low molecular weight heparins in patients with acute venous thromboembolism

Annals of Emergency Medicine

Volumn 39, Issue 5, 2002, Pages 555-557

  Rowe, Brian H ^a   Lang, Eddy S ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN;

ACUTE DISEASE; ADULT; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; FEMALE; HEPARINIZATION; HUMAN; LUNG EMBOLISM; MALE; MOLECULAR WEIGHT; MORTALITY; NOTE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; THROMBOEMBOLISM; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; EMERGENCY MEDICINE; EVIDENCE BASED MEDICINE; FOLLOW UP; PRACTICE GUIDELINE; RISK; TIME; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; CLINICAL TRIALS; CONFIDENCE INTERVALS; EMERGENCY MEDICINE; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ODDS RATIO; PRACTICE GUIDELINES; PULMONARY EMBOLISM; THROMBOEMBOLISM; TIME FACTORS; VENOUS THROMBOSIS;

EID: 0036241247     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2002.123591     Document Type: Article

References (5)

1. The rational clinical examination: Does this patient have deep vein thrombosis?
2. Antithrombatic therapy for venous thromboembolic disease
3. Home versus in-patient treatment for deep vein thrombosis (Cochrane review)
4. Protocols for deep venous thrombosis: A state-of-the-art review. Part I: Risk factor assessment, physical examination, and current diagnostic modalities
5. Economics of low-molecular weight heparins